REGENXBIO Inc. Common Stock (NASDAQ: RGNX) last traded at $10.72, down 3.07% on the session. The quote above updates while this page is open; the figures below are drawn from REGENXBIO Inc. Common Stock’s own filings and are restated only when a new one is published.
REGENXBIO Inc. Common Stock trades on NASDAQ under the ticker RGNX. Its market capitalisation is $707.66 million.
Valuation measures for REGENXBIO Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $707.66M |
|---|---|
| Enterprise value | $986.03M |
| Price / sales | 4.06 |
| Price / book | 9.86 |
| Beta | 1.92 |
Trailing-twelve-month figures tagged in REGENXBIO Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $174.48M |
|---|---|
| Net income (TTM) | -$196.43M |
| EPS (TTM) | -$3.79 |
| Operating margin | -94.08% |
| Return on equity | -273.72% |
| Cash | $36.49M |
Range and volume for RGNX over the past 52 weeks.
| 52-week high | $16.19 |
|---|---|
| 52-week low | $5.46 |
| Volume | 979.4K |
| Average volume | 1.92M |
| Previous close | $11.06 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.